Discover
RGNT
Regentis Biomaterials Ltd.
1.60
400 x 1.63
200 x 1.74
bid
ask
-
0.10
5.88%
300 @ 04:08 PM
1.71 +0.11 (6.63%)
| Ytd | -76.26% | |
| 1y | -78.67% |
1.60
day range
1.74
1.28
52 week range
9.40
| Open | 1.67 | Prev Close | 1.70 | Low | 1.60 | High | 1.74 | Mkt Cap | 11.24M |
| Vol | 22.21K | Avg Vol | 76.79K | EPS | -2.31 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.94 | 200-d Avg | 3.34 | 1yr Est | 0.00 |
| Income Statement | |||
| Weighted Average Shares | 5.95M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.95M | ||
| Cash and Equivalents (USD) | 8.95M | ||
| Current Assets | 9.29M | ||
| Property, Plant & Equipment Net | 64.00K | ||
| Total Assets | 9.35M | ||
| Debt Current | 11.00K | ||
| Total Debt | 29.00K | ||
| Current Liabilities | 1.65M | ||
| Debt Non-Current | 18.00K | ||
| Total Liabilities | 1.67M | ||
| Accumulated Retained Earnings (Deficit) | -58.39M | ||
| Shareholders Equity | 7.68M | ||
| Shareholders Equity (USD) | 7.68M | ||
| Assets Non-Current | 64.00K | ||
| Total Debt (USD) | 29.00K | ||
| Liabilities Non-Current | 18.00K | ||
| Trade and Non-Trade Payables | 1.64M | ||